{"id":"W3037338668","doi":"10.1136/annrheumdis-2019-216863","title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital; McMaster University; University of Toronto","funders":"National Institutes of Health; Canadian Institutes of Health Research; InflaRx; Vifor Pharma; Ministry of Health, Labour and Welfare; Genentech; University of Oxford; CSL Behring; National Institute for Health and Care Research; University of Utah; Insmed; Vasculitis Clinical Research Consortium; University of Pennsylvania; Kiniksa Pharmaceuticals; Mayo Clinic; Vasculitis Foundation; Medical Research Council; National Center for Research Resources; Versus Arthritis; Celgene; NIHR Cambridge Biomedical Research Centre; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; GlaxoSmithKline; University of Pittsburgh","keywords":"Medicine; Rituximab; Internal medicine; Granulomatosis with polyangiitis; Microscopic polyangiitis; Regimen; Vasculitis; Prednisone; Prospective cohort study; Population; Cohort; Cyclophosphamide; Surgery; Gastroenterology; Disease; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00191419,0.0003529901,0.0008389745,0.0001451163,0.000220015,0.000501645,0.0003715349,0.0005763845,0.001115656],"category_scores_gemma":[0.00191964,0.0001744909,0.0006324693,0.0001840827,0.0003357129,0.0003052677,0.000215388,0.0008421459,0.0001735653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002975823,"about_ca_system_score_gemma":0.0005998302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002904869,"about_ca_topic_score_gemma":0.0006423895,"domain_scores_codex":[0.9989066,0.0006721083,0.00006832633,0.0001450422,0.0001003226,0.0001075997],"domain_scores_gemma":[0.998912,0.0002905997,0.0004015266,0.00008801353,0.00004550298,0.0002624438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6077217,0.01865602,0.2348476,0.0006570627,0.002446468,0.0006155245,0.0003737209,0.0007779915,0.01749802,0.0001737904,0.001384539,0.1148476],"study_design_scores_gemma":[0.2750117,0.3764951,0.3371608,0.0001553879,0.001850761,0.001886185,0.0001672421,0.001492336,0.002860524,0.0001558973,0.002724305,0.00003981687],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981944,0.001346623,0.0000511401,0.00007077325,0.0000225427,0.00007636767,0.00006118918,0.000004686531,0.0001722974],"genre_scores_gemma":[0.9987005,0.00053058,0.000162614,0.0001204652,0.00008302304,0.0001217523,0.0001435344,0.000001755736,0.0001357425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00191419,"threshold_uncertainty_score":0.01012331,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0387124180293064,"score_gpt":0.3034553782608066,"score_spread":0.2647429602315002,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}